TFE3 fusions drive oxidative metabolism and ferroptosis resistance in translocation renal cell carcinoma by Alexandra Helleux, Guillaume Davidson, Antonin Lallement, Fatima Al Hourani, Alexandre Haller, Isabelle Michel, Anas Fadloun, Christelle Thibault-Carpentier, Xiaoping Su, Véronique Lindner, Thibault Tricard, Hervé Lang, Nizar M Tannir, Irwin Davidson, Gabriel G Malouf

Get full text

Neoadjuvant toripalimab combined with axitinib in patients with locally advanced clear cell renal cell carcinoma: a single-arm, phase II trial by Wei Zhang, Ding Zhang, Fan Xu, Wei Xue, Jin Zhang, Xiaorong Wu, Guangyu Wu, Jiwei Huang, Yueming Wang, Zaoyu Wang, Wen Kong, NG Cheoklong, Thibault Tricard, Wei Zhai, Jiyang Zhang, Shuyin Chen, Yuqing Lian, Yonghui Chen, Yiran Huang

Get full text

Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004): a phase 2 multicenter clinical trial by Emmanuel Seront, Ahmad Awada, Nieves Martinez Chanza, Philippe Barthélémy, Lieveke Ameye, Françoise Rothé, Aurélien Carnot, Nuria Kotecki, Sandrine Rorive, Thibault Tricard, Jérémy Blanc, Vinciane Casert, Brieuc Sautois, Jan Van den Brande, Vincent Vanhaudenarde, Lionel Staudacher, Veronique Debien, Jean-Christophe Fantoni, Thierry Roumeguère

Get full text